TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients

RAKOVÁ, J., TRUXOVÁ, I., HOLICEK, P., ŠÁLEK, C., HENSLER, M., KAŠÍKOVÁ, L., PASULKA, J., HOLUBOVÁ, M., KOVÁŘ, Marek, LYSÁK, D., KLINE, J. P., RÁČIL, Z., GALLUZZI, L., SPÍŠEK, R., FUČÍKOVÁ, J. TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients. Oncoimmunology. 2021, 10(1), 1889822. ISSN 2162-402X. E-ISSN 2162-402X. Available: doi: 10.1080/2162402X.2021.1889822.